When you develop and produce active pharma ingredients (API’s), there are always some impurities – identifying the chemical structure of the known ones is usually not a problem, but what about the unknown?

Whether the impurities are process-related or coming from the degradation of products they always need to be identified and classified accordingly.

With some of the best chemists in the industry using state of the art science and lab techniques, it now really is possible to identify the unidentified!

At QUINTA-ANALYTICA we offer structure elucidation, characterization, and full certification in both Research and Development (R&D) or Good Manufacturing Practice (GMP) mode. Our specialist labs are even able to do isotopically labeled compound enrichment.

With a global approach to business and multiple labs within central Europe, Quinta-Analytica is your true pharma partner.

Contact us today to learn more about the catalog of services we offer.

Additional News

  • 22 června 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency

  • 15 června 2023

    Novavax & Conscio: Behind the Scenes of Vaccine Development

    Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.

  • 8 června 2023

    Clinical Tips – Drug Interactions in Advanced Clinical Trial Design

    Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.